FDA Investigator Robert L Lewis, Jr
Robert L Lewis, Jr has inspections in 3 countries as of 17 Feb 2023. Robert L Lewis, Jr has collaborated with a combinined 1128 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
16
Last Inspection Date:
17 Feb 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Canada,
United States of America
Co-Investigator(s):
Aaron P Wozniak,
Adam R Cooke,
Anh M Lac,
Arindam Dasgupta, PhD,
Bonita S Chester,
Brandy N Lepage,
Brenda Rivera,
Carla J Lundi,
CDR Thomas R Berry, PPh,
Christie B Rice,
Christopher S Keating,
Claire M Minden,
Devaugh Edwards,
Devaughn Edwards,
Gabriel R Mclemore,
George J Flynn,
Geraldine D Sanders,
Hai Lien T Phung,
Ibad U Khan,
Ivy E Sweeney,
Jason F Chancey,
Jason K Morgan,
Jawaid Hamid,
Jawid Hamid,
Jennifer L Sheehan,
Johnetta F Walters,
Joseph F Owens,
Katherine Szestypalow,
Lareese K Thomas,
Larry K Hampton,
Laurie Nelson,
LCDR Debra Emerson,
Leah M Andrews,
Marie F Morin,
Matthew G Brown,
Melkamu Getie Kebtie, PhD,
Myoshi M Francis,
Nakesha J Jackson,
Nancy E Fontaine,
Nancy E Ford,
Nicole E Knowlton,
Patrick D Stone, MS,
Patsy J Domingo,
Paula R Katz,
Penny H Mccarver,
Qin Xu,
Rachael L Cook,
Robert C Coleman,
Samantha J Pinizzotto, D V M,
Santos E Camara,
Sarah E Mcmullen,
Sena G Dissmeyer,
Seneca D Toms,
Sripal R Mada, PhD,
Steven Fong, MS, PhD,
Susan O Oladeji,
Susanna E Ford, Analyst,
Suzanne N Vallez,
Tracy R Ball,
Vickie J Kanion,
Vicky C Stoakes,
Viviana Matta,
Yumi J Hiramine,
Zhao Wang, PhD
Robert L Lewis, Jr's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2000 | FDA 483 | Piedmont LLC dba Voyant Beauty - Form 483, 2000-01-18 |
April, 2000 | FDA 483 | Solvay USA Inc. - Form 483, 2000-04-27 |
April, 2000 | EIR | Solvay USA Inc. - EIR, 2000-04-27 |
April, 2000 | FDA 483 Response | Solvay USA Inc. - Form 483R, 2000-06-02 |
May, 2000 | EIR | Alcami Carolinas Corporation - EIR, 2000-05-25 |
May, 2000 | FDA 483 | Pharmaceutical Development Center, Inc - Form 483, 2000-05-25 |
May, 2000 | EIR | Solvay Pharmaceuticals Inc - EIR, 2000-05-19 |
January, 2000 | EIR | Piedmont LLC dba Voyant Beauty - EIR, 2000-01-18 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more